A Cornell-led collaboration used machine learning to pinpoint the most accurate means, and timelines, for anticipating the advancement of Alzheimer’s disease.
New research finds that cells are much more precise in how they ingest substances than previously thought, opening the door to potential treatments for several diseases.
Robert J. “Bob” Appel ’53, a vice chair of Weill Cornell Medicine’s Board of Fellows, Cornell trustee emeritus and presidential councillor, died Nov. 19 in New York, at age 91.
The documentary, which will debut nationwide on PBS March 21, illustrates the full scope of his career set against the backdrop of his final years of service presiding over the nation’s response to the COVID-19 pandemic.
The Cornell Board of Trustees and Weill Cornell Medicine Board of Fellows have approved the appointment of Dr. Francis Lee as interim dean of Weill Cornell Medicine and interim provost for medical affairs.
A Cornell-led group of researchers has developed an online search method that employs natural language processing to identify terms that are semantically similar to those for cancer screening tests, but in colloquial language.
A growing percentage of U.S. adults, even those who trust science, said harassing or threatening public health officials over COVID-19 business closures was justified, according to a new study of public opinion surveys conducted during two phases of the pandemic.
New research in biomechanics measures the impact of head-first, hand-first and feet-first diving and the likelihood of injury at different diving heights.
A study suggests boosting “naturally-produced” antibodies in mothers may enhance infants’ immunity against bacterial pathogens that cause infectious gastrointestinal diseases.
Researchers at Weill Cornell Medicine have developed a pre-clinical model of the leading cause of central vision loss in older individuals, dry age-related macular degeneration, and used it to identify new treatment modalities and drug targets.